Ayurvedic Approach to Cardiovascular Diseases: Delineating the Literary and Clinical Evidences

  • Sanjeev Rastogi
  • Rajiv Rastogi
  • P. S. Srivastav


Cardiovascular diseases are increasing to the size which accounts them a big cause of mortality second only to cancer. Lifestyle modifications have proved their worth in reverting many related ailments. CAM approaches are also being repeatedly claimed for their role in various cardiovascular conditions. This chapter reviews the understanding of cardiac diseases (hrida roga) in an Ayurvedic perspective and also reviews the available evidences in support of any claim of Ayurveda to deal such conditions.


Prevent Heart Disease Coleus Forskohlii Rigorous Clinical Trial Treat Heart Disease Elemental Imbalance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Rastogi S (2009) Ayurveda for comprehensive health care. Indian J Med Ethics 6:101–102PubMedGoogle Scholar
  2. 2.
    Valiathan MS (2009) An Ayurvedic view of life. Curr Sci 96:1186–1192Google Scholar
  3. 3.
    Singh RH (2010) Exploring larger evidence-base for contemporary Ayurveda. Int J Ayurveda Res 1:65–66PubMedCrossRefGoogle Scholar
  4. 4.
    Kales SN, Saper RB (2009) Ayurvedic lead poisoning: an under-recognized, international problem. Indian J Med Sci 63:379–381PubMedCrossRefGoogle Scholar
  5. 5.
    Traditional medicine. Downloaded from Accessed on 16 July 2011
  6. 6.
    Rastogi S, Chiappelli F (2010) Bringing evidence basis to decision making in Complementary and Alternative Medicine (CAM): Prakriti (constitution) analysis in Ayurveda. In: Chiappelli F, Caldeira Brant XM, Neagos N, Oluwadara OO, Ramchandani MH (eds) Evidence-based practice toward optimizing clinical outcomes. Springer, Berlin Heidelberg, pp 91–106CrossRefGoogle Scholar
  7. 7.
    Rastogi S (2010) Building bridges between Ayurveda and modern science. Int J Ayurveda Res 1:41–46PubMedCrossRefGoogle Scholar
  8. 8.
    Ghodke Y, Joshi K, Patwardhan B (2011) Traditional medicine to modern pharmacogenomics: Ayurveda Prakriti type and CYP2C19 gene poly morphism associated with the metabolic variability. Evid Based Complement Altern Med. Article ID 249528, DOI:10.1093/ecam/nep 206Google Scholar
  9. 9.
    Brunton TL (1885) A text-book of pharmacology, therapeutics and materia medica. Macmillan and Co., LondonGoogle Scholar
  10. 10.
    Beauchamp GK, Keast RS, Morel D, Lin J, Pika J, Han Q et al (2005) Breslin phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature 437:45–46PubMedCrossRefGoogle Scholar
  11. 11.
    Joshi K, Hankey A, Patwardhan B (2007) Traditional phytochemistry: identification of drug by ‘taste’. Evid Based ComplementAltern Med 4:145–148CrossRefGoogle Scholar
  12. 12.
    Tripathi BN (ed) (1983) Charaka Samhita Sutra Sthana 30/3. Chaukhambha Surbharti Prakashana, VaranasiGoogle Scholar
  13. 13.
    Shastri AD (ed) (2007) Sushruta Samhita, Sharira Sthana 4/31. Chaukhambha Sanskrit Sanssthana, VaranasiGoogle Scholar
  14. 14.
    Alaeddini J, Shirani J (2009) Anginapectoris. Downloaded from Accessed on 17 July 2011
  15. 15.
    Davies MJ (1997) The composition of coronary artery plaques. N Engl J Med 336:1312–1314PubMedCrossRefGoogle Scholar
  16. 16.
    Yadav RK (1978) A clinical study of an indigenous compound on sannipataja hrida roga with special reference to congestive heart failure. M.D. thesis, SAC, Lucknow University, IndiaGoogle Scholar
  17. 17.
    Birthray MK (1981) Clinical ayurvedic studies on congestive heart failure. M.D. thesis, SAC, Lucknow, IndiaGoogle Scholar
  18. 18.
    Chandel PS (1983) Clinical classical studies and effect of herbal compounds (Arjunadi kashaya) on Hridaroga—Congestive cardiac failure. M.D. thesis, SAC, Lucknow University, IndiaGoogle Scholar
  19. 19.
    Nigam RP (1981) A clinical trial of arogyavardhini (Herbal) in cases of raised rakta gata sneha (Hyperlipidaemia). M.D. thesis, SAC, Lucknow University, IndiaGoogle Scholar
  20. 20.
    Dwivedi P (1983) Effect of sarpagandhadi yoga and savasana on hypertension with a comparative study to vyana prakop. M.D. thesis, SAC, Lucknow University, IndiaGoogle Scholar
  21. 21.
    Raguvanshi K (1987) Clinical evaluation of sarpagandhadi compound on hypertension. M.D. thesis, SAC, Lucknow University, IndiaGoogle Scholar
  22. 22.
    Srivastava VS (1985), Effect of jatamansyadi yoga on essential hypertension a clinical study. M.D. thesis, SAC, Lucknow University, IndiaGoogle Scholar
  23. 23.
    Kumar R (1991) Further observation on the effect of alcoholic extract of coleus Forskohlii Briq root in cases of hypertension. M.D. thesis, SAC, Lucknow University, IndiaGoogle Scholar
  24. 24.
    Jain JK (1988) Observation on the effect of alcoholic extract of Coleus forskohlii briq root in cases of hypertension. M.D. thesis, SAC, Lucknow University, IndiaGoogle Scholar
  25. 25.
    Srivastav PS (1978) Therapeutic trial of Coleus forskohlii Briq (Changla jari) on the patients of systemic arterial hypertension. M.D. thesis, SAC, Lucknow University, IndiaGoogle Scholar
  26. 26.
    Sharma H, Chandola HM, Singh G, Basisht G (2007) Utilisation of Ayurveda in Health care: An approach for prevention, health promotion and treatment of disease. Part 2-Ayurveda in primary health care. J Alt Comp Med 13:1135–1150Google Scholar
  27. 27.
    Clinical trials on Ayurveda. Available at Last accessed on 20 May 2011
  28. 28.
    Cochrane review on Ayurveda. Available at Last accessed on 23 May 2011
  29. 29.
    Ayurveda and cardiovascular disease. Available at Last accessed on 17 Sept 2011
  30. 30.
    Sen G, Bose KC (1931) Rauwolfia serpentina, a new Indian drug for insanity and high blood pressure. Indian Med World 2:194Google Scholar
  31. 31.
    Bharani A, Ganguli A, Bhargava KD (1995) Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure. Int J Cardiol l49:191–199CrossRefGoogle Scholar
  32. 32.
    Gupta R, Singhal S, Goyle A, Sharma VN (2001) Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebo-controlled trial. J Assoc Physicians India 49:231–235PubMedGoogle Scholar
  33. 33.
    Bharani A, Ganguli A, Mathur LK, Jamra Y, Raman PG (2002) Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. Indian Heart J 54:170–175PubMedGoogle Scholar
  34. 34.
    Malik N, Dhawan V, Bahl A, Kaul D (2009) Inhibitory effect of Terminalia arjuna on platelet activation in vitro in healthy subjects and in patients of coronary heart disease. Platelets 20:183–190PubMedCrossRefGoogle Scholar
  35. 35.
    Apte V (1998) Monograph on Guggul and Guggul kalpa (monograph in Marathi). MumbaiGoogle Scholar
  36. 36.
    Satyavati GV, Dwarakanath C, Tripathi SN (1969) Experimental studies on the hypocholesterolemic effect of Commiphora mukul Engl (Guggul). Indian J Med Res 57:1950–1952PubMedGoogle Scholar
  37. 37.
    Nityanand S, Kapoor NK (1971) Hypocholesterolemic effect of Commiphora mukul resin (Guggal). Indian J Exp Biol 9:376–379PubMedGoogle Scholar
  38. 38.
    Rastogi S, Ranjana, Singh RH (2007) Adverse effects of Ayurvedic drugs: an overview of causes and possibilities in reference to a case of Vatsanabha (Aconite) overdosing. Int J Risk Saf Med 19:117–125Google Scholar
  39. 39.
    Dhesi P, Ng R, Shehata MM, Shah PK (2010) Ventricular tachycardia after ingestion of Ayurveda herbal antidiarrhoeal preparation containing aconitum. Arch Intern Med 170:303–305PubMedCrossRefGoogle Scholar
  40. 40.
    Yeh GY, Davis RB, Phillips RS (2006) Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol 98:673–680PubMedCrossRefGoogle Scholar
  41. 41.
    Miller KL, Liebowitz RS, Newby LK (2004) Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches. Am Heart J 147:401–411PubMedCrossRefGoogle Scholar
  42. 42.
    Available at Last accessed on 20 Nov 2010
  43. 43.
    Mamtani R, Mamtani R (2005) Ayurveda and yoga in cardiovascular diseases. Cardiol Rev 13:155–162PubMedCrossRefGoogle Scholar
  44. 44.
    Boden WE, O’Rourke RA, Teo KK, Hartigan PM et al (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356:1503–1516PubMedCrossRefGoogle Scholar
  45. 45.
    Manchanda SC, Narang R, Reddy KS, Sachdeva U, Prabhakaran D, Dharmanand S, Rajani M, Bijlani R (2000) Retardation of coronary atherosclerosis with yoga lifestyle intervention. J Assoc Physicians India 48:687–694PubMedGoogle Scholar
  46. 46.
    Yogendra J, Yogendra HJ, Ambardekar S, Lele RD, Shetty S, Dave M, Husein N (2004) Beneficial effects of yoga lifestyle on reversibility of ischemic heart disease: caring heart project of international board of yoga. J Assoc Physicians India 52:283–289PubMedGoogle Scholar
  47. 47.
    Pal A, Srivastava N, Tiwari S, Verma NS, Narain VS, Agrawal GG, Natu SM, Kumar K (2011) Effect of yogic practices on lipid profile and body fat composition in patients of coronary artery disease. Complement Ther Med 19:122–127PubMedCrossRefGoogle Scholar
  48. 48.
    Rastogi R (2011) Naturopathic and yogic intervention in the management of coronary artery disease. Light Ayur J 10:49–54Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Sanjeev Rastogi
    • 1
  • Rajiv Rastogi
    • 2
  • P. S. Srivastav
    • 1
  1. 1.PG Department of Kaya Chikitsa, State Ayurvedic CollegeLucknow UniversityLucknowIndia
  2. 2.Department of AyushCentral Council for Research in Yoga and Naturopathy, MOH&FWNew DelhiIndia

Personalised recommendations